Pharmagreen Biotech Inc.
PHBI
$0.0012
$0.00019.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -226.30K | -1.00M | -403.90K | -524.30K | -674.30K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 11.90K | 54.40K |
| Total Other Non-Cash Items | -68.10K | 724.90K | 82.30K | 170.20K | 231.10K |
| Change in Net Operating Assets | 261.40K | 251.50K | 264.90K | 293.60K | 332.40K |
| Cash from Operations | -33.00K | -28.10K | -56.80K | -48.60K | -56.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 42.40K | 28.70K | 28.10K | 45.30K | 33.40K |
| Total Debt Repaid | -100.00 | -100.00 | -100.00 | -100.00 | 2.60K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42.20K | 28.50K | 27.90K | 45.10K | 35.90K |
| Foreign Exchange rate Adjustments | -9.10K | -1.40K | 23.70K | -3.40K | -3.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.00 | -1.00K | -5.10K | -6.90K | -24.30K |
